AFP and hepatocellular carcinoma: Noticeably, the proportion of AFP > 1× ULN was also significantly higher in the non-antiviral group than in the antiviral group both for patients with non-HCC (37.3% vs. 11.4%, p < 0.001) and early-stage HCC (66.7% vs. 53.6%, p < 0.001).